Jun 17, 2025 06:46AM
Jun 17, 2025 06:45AM
May 14, 2025 07:00AM
Apr 15, 2025 06:09AM
Apr 14, 2025 07:00AM
Apr 14, 2025 07:00AM
Apr 11, 2025 07:00AM Verve Therapeutics (VERV) Receives U.S. FDA Fast Track Designation for VERVE-102, an In Vivo Base Editing Medicine Targeting PCSK9
Apr 11, 2025 07:00AM
Apr 1, 2025 07:00AM
Mar 25, 2025 09:10AM
Mar 25, 2025 06:38AM
Mar 24, 2025 07:00AM
Mar 24, 2025 07:00AM
Dec 19, 2024 09:42AM Stifel Names Top Picks in Biotechnology 2025 Outlook Note
Apr 2, 2024 07:02AM
Apr 2, 2024 07:00AM
Feb 27, 2024 07:30AM
Nov 13, 2023 05:34AM
Nov 12, 2023 03:30PM
Nov 7, 2023 06:30AM
Oct 23, 2023 06:31AM Verve Therapeutics (VERV) Announces FDA Clearance of NDA for VERVE-101
Oct 23, 2023 06:30AM
Aug 10, 2023 06:30AM
May 15, 2023 06:31AM
May 15, 2023 06:30AM
Mar 2, 2023 06:30AM
Mar 2, 2023 06:30AM
Dec 15, 2022 03:59AM Goldman Sachs Starts Verve Therapeutics (VERV) at Sell
Nov 7, 2022 06:30AM
Nov 7, 2022 06:30AM
Nov 7, 2022 06:30AM
Aug 24, 2022 04:47PM
Apr 26, 2022 06:30AM
Apr 26, 2022 06:30AM
Apr 26, 2022 06:30AM Verve Therapeutics Presents Comprehensive Analyses of Off-target Editing Risk for VERVE-101 at Precision Genome Engineering Keystone Symposia
Mar 14, 2022 06:31AM
Mar 14, 2022 06:30AM
Mar 14, 2022 06:30AM
Jan 12, 2022 06:14AM

322,206 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All